| A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Guide to interpreting this cost-effectiveness analysis | ||||||||||||||||||
| 2 | Sheet descriptions | ||||||||||||||||||
| 3 | |||||||||||||||||||
| 4 | Simple CEA | This sheet contains a simplified version of the CEA that is designed to be comparable to our CEAs of other programs. | |||||||||||||||||
| 5 | Main CEA | This sheet contains the primary calculations that result in final cost-effectiveness estimates. This sheet draws on inputs from the "Inputs" sheet and inputs calculated in the other supplemental sheets listed below. The sheet is structured into four distinct benefit streams: 1. Direct benefit of the grant we are funding to support scale-up of ILC in Andhra Pradesh and Madhya Pradesh 2. Direct benefit of a future grant we may fund to continue supporting scale-up of ILC in Andhra Pradesh and Madhya Pradesh 3. Indirect benefit that grants to support scale-up of ILC in Andhra Pradesh and Madhya Pradesh may have on independent government scale-up of ILC in other states 4. Direct benefit of future grants we may fund to support scale-up of ILC in other states See a full breakdown and explanation of the calculations on the sheet. | |||||||||||||||||
| 6 | Program reach | This sheet contains calculations estimating the number of additional people that we expect will be reached with water treatment due to this grant, split up across the four benefit streams detailed above. | |||||||||||||||||
| 7 | Program costs | This sheet contains calculations estimating programmatic costs, again split up across the benefit streams detailed above (excluding benefit stream #3, for which no additional costs are incurred). | |||||||||||||||||
| 8 | ILC benefits | This sheet contains calculations estimating the benefits that receiving ILC has on averting mortality and morbidity (among individuals under and over 5 years) and increasing the long-term earnings of children under 15 (via improved development). | |||||||||||||||||
| 9 | Inputs | This sheet contains all of the manually entered input values informing the CEA, along with the sources and reasoning supporting them. This sheet also contains inputs sourced from the "Source data" sheet. | |||||||||||||||||
| 10 | Source data | This sheet contains datasets downloaded from the Institute of Health Metrics (IHME)'s Global Burden of Disease (GBD) project, and from Jal Jeevan Mission (JJM) databases. | |||||||||||||||||
| 11 | |||||||||||||||||||
| 12 | Terminology key | ||||||||||||||||||
| 13 | |||||||||||||||||||
| 14 | Terms specific to this CEA | ||||||||||||||||||
| 15 | ILC | This acronym refers to "in-line chlorination" devices installed onto water tanks, which automatically dispense chlorine into the water. | |||||||||||||||||
| 16 | JJM | This acronym refers to the "Jal Jeevan Mission," a scheme initiated by the Indian government to expand access to safe water among rural households in India. JJM is the entity responsible for installing piped water infrastructure, on top of which ILC devices supported by Evidence Action's program will be installed. | |||||||||||||||||
| 17 | SVS | This refers to the "single-village-scheme" JJM designation, which are the sites where we expect Evidence Action's program will support ILC device installation and maintenance. | |||||||||||||||||
| 18 | MVS | This refers to the "multi-village-scheme" JJM designation. These are not sites in which we expect the current grant to support ILC device installation and maintenance, though we think it's plausible that device rollout in SVS sites could influence wider rollout in MVS sites. | |||||||||||||||||
| 19 | Person-year of effective coverage | We use "effective coverage" to refer to a level of protection equivalent to the protection provided in the studies of water chlorination we rely on. A "person-year" refers to the equivalent of one person receiving one year of effective coverage. | |||||||||||||||||
| 20 | |||||||||||||||||||
| 21 | Terms used across GiveWell's CEAs | ||||||||||||||||||
| 22 | Internal validity | Describes an adjustment we make to the treatment effect of an intervention to account for the possibility that the treatment effects found in studies may not represent the true effect the intervention had on the populations studied. | |||||||||||||||||
| 23 | External validity | Describes an adjustment we make to the treatment effect of an intervention to account for differences in the program implementation or populations treated in studies from the program implementation or populations treated by grantee programs. | |||||||||||||||||
| 24 | Leverage | Describes a situation where a grantee's spending on a program causes other organizations or governments to contribute more to the program than they otherwise would have. In most cases, accounting for leverage increases cost-effectiveness. | |||||||||||||||||
| 25 | Funging | Describes a situation where a grantee's spending on a program causes other organizations or governments to contribute less to the program than they otherwise would have. In most cases, accounting for funging decreases cost-effectiveness. | |||||||||||||||||
| 26 | Counterfactual | In most cases, describes the state of the world that would exist if we did not provide funding to a grantee for a program. When discussing the "counterfactual value of other actors' spending," we are referring to how much benefit another organization's or government's spending would generate if it were spent on something other than the grantee program. | |||||||||||||||||
| 27 | Moral weights | To compare cost-effectiveness across different programs, we use ‘moral weights’ to quantify the benefits of different program impacts (e.g., increased income vs reduced deaths). We benchmark the value of each benefit to a value of 1, which we define as the value of doubling someone’s consumption for one year. | |||||||||||||||||
| 28 | Philanthropic actors | Non-governmental organizations (NGOs) providing funding to philanthropic programs. | |||||||||||||||||
| 29 | |||||||||||||||||||
| 30 | Unit and source key | ||||||||||||||||||
| 31 | |||||||||||||||||||
| 32 | Unit labels used in the CEA | ||||||||||||||||||
| 33 | # | Number | |||||||||||||||||
| 34 | per 1k | Rate per 1,000 | |||||||||||||||||
| 35 | per 100k | Rate per 100,000 | |||||||||||||||||
| 36 | $ | U.S. dollars | |||||||||||||||||
| 37 | % | Percentage | |||||||||||||||||
| 38 | ppt | Percentage points | |||||||||||||||||
| 39 | UoV | Units of value: an arbitrary unit GiveWell uses to compare the moral value of different types of outcomes, such as saving lives or increasing income | |||||||||||||||||
| 40 | xcash | Cost-effectiveness in terms of multiples of GiveDirectly's unconditional cash transfer program | |||||||||||||||||
| 41 | |||||||||||||||||||
| 42 | Source labels used in the CEA | ||||||||||||||||||
| 43 | |||||||||||||||||||
| 44 | input | A value pulled from the "Inputs" sheet | |||||||||||||||||
| 45 | calc | A value calculated using other values in the same sheet | |||||||||||||||||
| 46 | supp | A value pulled from one of the sheets hosting supplemental calculations | |||||||||||||||||
| 47 | main | A value pulled fom the "Main CEA" sheet | |||||||||||||||||
| 48 | feed | A value pulled from a different section within the same sheet | |||||||||||||||||
| 49 | |||||||||||||||||||
| 50 | GiveWell analyses informing this model | ||||||||||||||||||
| 51 | |||||||||||||||||||
| 52 | Analyses specific to this CEA | ||||||||||||||||||
| 53 | GW's analysis of the effect of water chlorination | ||||||||||||||||||
| 54 | GW's water quality cost-effectiveness analysis | ||||||||||||||||||
| 55 | GiveWell, Report on possible IHME misclassification of enteric infection mortality | ||||||||||||||||||
| 56 | GiveWell,  Water quality in selected Indian states vs. chlorination RCTs (unpublished) | ||||||||||||||||||
| 57 | GW's development effects estimation model for ILC in India | ||||||||||||||||||
| 58 | |||||||||||||||||||
| 59 | Analyses referenced across GiveWell's CEAs | ||||||||||||||||||
| 60 | GW's moral weights and discount rate | ||||||||||||||||||
| 61 | GW's supplemental intervention-level adjustments | ||||||||||||||||||
| 62 | GW's analysis of the counterfactual value of Global Fund spending | ||||||||||||||||||
| 63 | |||||||||||||||||||